Fundz
Real-time · AI · Cross-signal

Galapagos Biopharma just moved. Here's exactly what to do next.

Who to reach, what to say, and why now — on Galapagos Biopharma, plus every contract, funding round, and exec hire that follows. Verified, ICP-ranked contacts on demand (email + mobile).

Used by professionals at BlackRock, Oracle, Kleiner Perkins, HubSpot, and other leading firms — built on 10 years of proprietary signal data.

Choose your planRequest a demo
▶
Watch the 2-minute tour · with sound

Galapagos Announces €2.45B Capitalization for Spin-Off Company to Develop Medicines With Gilead Partnership

Jan 08, 2025•over 1 year ago

Contract Type

partnership

BelgiumBiotechnologyPharmaceuticalBiopharma

Description

Galapagos has announced the creation of a new company, called SpinCo, capitalized with €2.45 billion from Galapagos. The new company will independently develop a variety of new medicines, including those with clinical proof-of-concept in oncology, immunology, and virology. SpinCo will also inherit a collaboration agreement with Gilead Sciences signed in 2019. This move will result in Galapagos and SpinCo becoming two separate publicly traded companies, with Galapagos focusing on cell therapy.

Company Information

Company

Galapagos Biopharma

Location

Belgium

About

Galapagos Biopharma is a Belgian biopharmaceutical company with a focus on the development of innovative medicines to address unmet medical needs. It has a strong presence in the European pharmaceutical market.

Predictive Intelligence
Strategic

ML-powered predictions for Galapagos Biopharma's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.